Cargando…
Genetic analysis in the clinical management of biliary tract cancer
Biliary tract cancer (BTC) is clinically and pathologically heterogeneous and responds inadequately to treatment. A small section of patients develop resectable disease, although the relapse rates are high; the benefits of adjuvant capecitabine chemotherapy for BTC are now understood, and gemcitabin...
Autores principales: | Wakai, Toshifumi, Nagahashi, Masayuki, Shimada, Yoshifumi, Prasoon, Pankaj, Sakata, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382432/ https://www.ncbi.nlm.nih.gov/pubmed/32724874 http://dx.doi.org/10.1002/ags3.12334 |
Ejemplares similares
-
Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis
por: Hirose, Yuki, et al.
Publicado: (2018) -
Next generation sequencing‐based gene panel tests for the management of solid tumors
por: Nagahashi, Masayuki, et al.
Publicado: (2018) -
Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation
por: Yuza, Kizuki, et al.
Publicado: (2020) -
Genomic characterization of colitis-associated colorectal cancer
por: Kameyama, Hitoshi, et al.
Publicado: (2018) -
Unveiling microbiome profiles in human inner body fluids and tumor tissues with pancreatic or biliary tract cancer
por: Okuda, Shujiro, et al.
Publicado: (2022)